rss
J Clin Pathol 56:96-102 doi:10.1136/jcp.56.2.96
  • Review

Ewing’s sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities

Table 1

EWS fusion types described in Ewing’s sarcoma family of tumours (ESFT) and other sarcomas

Translocation Gene fusion Tumour type (% of tumours with this EWS gene rearrangement)
The presence of EWS–ETS gene rearrangements is increasingly used to define ESFT. The involvement of the EWS gene on chromosome 22q is consistent; this can partner with several different ETS gene family members located on various chromosomes, but most frequently with FLI1 on chromosome 11 in ESFT. Rearrangements of the EWS gene on chromosome 22q12 with other chromosomes have also been described in other less common sarcoma types (shown in italics).
t(11;22)(q24;q12) EWS–FLI1 ESFT (85%)
t(21;22)(q22;q12) EWS–ERG ESFT (10%)
t(7;22)(p22;q12) EWS–ETV1 ESFT (rare)
t(17;22)(q12;q12) EWS–E1AF ESFT (rare)
t(2;22)(q33;q12) EWS–FEV ESFT (rare)
t(12;22)(q13;q12) EWS–AFT1 Clear cell sarcoma
t(11;22)(q13;q12) EWS–WT1 Desmoplastic small round cell tumour
t(9;22)(q22;q12) EWS–CHN Myxoid chondrosarcoma
t(12;22)(q13;q12) EWS–CHOP Myxoid liposarcoma

This Article

Latest from JCP Education

Latest from JCP Education

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JCP.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest Pathology jobs

Latest Pathology jobs